As a potential candidate tumor suppressor gene, the overexpression of PARK2 leads to cell cycle arrest, accelerated apoptosis, reduced cell proliferation, migration, invasion capabilities, and decreased angiogenesis. The gene discussed is PRKN; the disease is neoplasm.